1.
Int J Urol
; 18(2): 94-101, 2011 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-21073543
RESUMEN
At present, immunotherapy in urological malignancy is experiencing a renaissance, particularly with the emergence of a host of innovative cancer vaccines. Herein, we will review promising immunotherapeutic approaches and evaluate the data supporting their inclusion in novel combination strategies.
